Future studies will explicitly investigate whether FGFC1 induces ER stress markers (e.g., GRP78, CHOP, XBP1 splicing) and evaluate its contribution to caspase-3 activation in Ara-C-resistant AML cells. This evidence concerns the gene CASP3 and acute myeloid leukemia.